THC Farmaceuticals, Inc.
CBDG · OTC
6/30/2022 | 3/31/2022 | 12/31/2021 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $1,813 | $2,502 | $1,106 | $4,823 |
| - Cash | $7 | $10 | $11 | $3 |
| + Debt | $386 | $383 | $342 | $342 |
| Enterprise Value | $2,193 | $2,875 | $1,437 | $5,162 |
| Revenue | $0 | $0 | $10 | $5 |
| % Growth | – | -100% | 98.9% | – |
| Gross Profit | -$1 | -$1 | $9 | $5 |
| % Margin | – | – | 90.5% | 100% |
| EBITDA | -$5 | -$10 | -$1 | $116 |
| % Margin | – | – | -7.4% | 2,298.7% |
| Net Income | -$3 | -$6 | -$1 | $58 |
| % Margin | – | – | -8.4% | 1,149.3% |
| EPS Diluted | -0 | -0 | -0 | 0.004 |
| % Growth | 33.3% | -501.5% | -101.4% | – |
| Operating Cash Flow | -$4 | -$4 | -$7 | -$13 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$4 | -$4 | -$7 | -$13 |